drugset / Trial / NCT00068445

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00068445

RandomizedParallel-groupDouble-blindSupportive care

Summary

RATIONALE: Lamotrigine may be effective in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy. It is not yet known whether lamotrigine is effective in treating peripheral neuropathy caused by chemotherapy. PURPOSE: This randomized phase III trial is studying how well lamotrigine works in reducing pain, numbness, tingling, and other symptoms of peripheral neuropathy caused by chemotherapy in patients with cancer.

Timeline

Start
2004-02
Primary completion
2006-05
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Lamotrigine Small molecule 300 mg Oral